Item3.03.
Material Modification to Rights of Security Holders.
Cyclo Therapeutics, Inc., a Nevada corporation (the "Company") convened and adjourned a special meeting of stockholders on (the "Special Meeting") on December 26, 2023. At the Special Meeting, the Company's stockholders approved an amendment to Cyclo's Articles of Incorporation, as amended (the "Share Increase Amendment") to effect a share increase of the number of authorized shares of the Company's common stock from 50,000,000 shares to 250,000,000 shares (the "Share Increase"). In addition to the Share Increase Amendment, the Company's stockholders approved other proposals at the Company's Special Meeting, which were described in the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on December 26, 2023.
On December 26, 2023, the Company filed the Share Increase Amendment with the Secretary of State of the State of Nevada to effect the Share Increase Amendment, which became on December 26, 2023. The foregoing descriptions of the Share Increase Amendment was qualified in their entirety by reference to the Share Increase Amendment, a copy of which is attached hereto as Exhibit 3.1 and are incorporated herein by reference.

Attachments

Disclaimer

Cyclo Therapeutics Inc. published this content on 28 December 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 28 December 2023 21:30:40 UTC.